nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurbiprofen—PTGS2—thyroid cancer	0.328	1	CbGaD
Flurbiprofen—UGT2B7—Epirubicin—thyroid cancer	0.116	0.245	CbGbCtD
Flurbiprofen—UGT1A9—Sorafenib—thyroid cancer	0.107	0.226	CbGbCtD
Flurbiprofen—ABCC4—Sorafenib—thyroid cancer	0.0898	0.189	CbGbCtD
Flurbiprofen—UGT1A1—Sorafenib—thyroid cancer	0.0878	0.185	CbGbCtD
Flurbiprofen—ALB—Vandetanib—thyroid cancer	0.0552	0.116	CbGbCtD
Flurbiprofen—CYP2C9—Sorafenib—thyroid cancer	0.0179	0.0378	CbGbCtD
Flurbiprofen—Carprofen—PTGS2—thyroid cancer	0.000526	0.124	CrCbGaD
Flurbiprofen—Tiaprofenic acid—PTGS2—thyroid cancer	0.000428	0.101	CrCbGaD
Flurbiprofen—Fenbufen—PTGS2—thyroid cancer	0.00039	0.0922	CrCbGaD
Flurbiprofen—Ibuprofen—PPARG—thyroid cancer	0.000385	0.0911	CrCbGaD
Flurbiprofen—Diflunisal—PTGS2—thyroid cancer	0.000375	0.0886	CrCbGaD
Flurbiprofen—Oxaprozin—PTGS2—thyroid cancer	0.000339	0.0801	CrCbGaD
Flurbiprofen—Salsalate—PTGS2—thyroid cancer	0.000339	0.0801	CrCbGaD
Flurbiprofen—Suprofen—PTGS2—thyroid cancer	0.000325	0.0768	CrCbGaD
Flurbiprofen—PTGS1—Overview of nanoparticle effects—PTGS2—thyroid cancer	0.000284	0.00716	CbGpPWpGaD
Flurbiprofen—Fenoprofen—PTGS2—thyroid cancer	0.00028	0.0662	CrCbGaD
Flurbiprofen—Mefenamic acid—PTGS2—thyroid cancer	0.00026	0.0614	CrCbGaD
Flurbiprofen—Naproxen—PTGS2—thyroid cancer	0.000255	0.0603	CrCbGaD
Flurbiprofen—UGT1A9—PPAR Alpha Pathway—CCND1—thyroid cancer	0.000245	0.00617	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—MINPP1—thyroid cancer	0.000239	0.00602	CbGpPWpGaD
Flurbiprofen—Dyspnoea—Sorafenib—thyroid cancer	0.000237	0.00154	CcSEcCtD
Flurbiprofen—UGT1A3—NRF2 pathway—SLC5A5—thyroid cancer	0.000237	0.00596	CbGpPWpGaD
Flurbiprofen—PTGS1—Eicosanoid Synthesis—PTGS2—thyroid cancer	0.000236	0.00594	CbGpPWpGaD
Flurbiprofen—Lymphadenopathy—Epirubicin—thyroid cancer	0.000235	0.00153	CcSEcCtD
Flurbiprofen—Nausea—Vandetanib—thyroid cancer	0.000234	0.00152	CcSEcCtD
Flurbiprofen—Dyspepsia—Sorafenib—thyroid cancer	0.000234	0.00152	CcSEcCtD
Flurbiprofen—Coma—Doxorubicin—thyroid cancer	0.000233	0.00152	CcSEcCtD
Flurbiprofen—Oesophagitis—Doxorubicin—thyroid cancer	0.000233	0.00152	CcSEcCtD
Flurbiprofen—Phlebitis—Epirubicin—thyroid cancer	0.000232	0.00151	CcSEcCtD
Flurbiprofen—Decreased appetite—Sorafenib—thyroid cancer	0.000231	0.00151	CcSEcCtD
Flurbiprofen—Bladder pain—Doxorubicin—thyroid cancer	0.000231	0.0015	CcSEcCtD
Flurbiprofen—Ecchymosis—Doxorubicin—thyroid cancer	0.000231	0.0015	CcSEcCtD
Flurbiprofen—Photosensitivity—Epirubicin—thyroid cancer	0.000228	0.00148	CcSEcCtD
Flurbiprofen—Pain—Sorafenib—thyroid cancer	0.000228	0.00148	CcSEcCtD
Flurbiprofen—Constipation—Sorafenib—thyroid cancer	0.000228	0.00148	CcSEcCtD
Flurbiprofen—Vascular purpura—Epirubicin—thyroid cancer	0.000224	0.00146	CcSEcCtD
Flurbiprofen—Hypertonia—Doxorubicin—thyroid cancer	0.000224	0.00145	CcSEcCtD
Flurbiprofen—Eczema—Epirubicin—thyroid cancer	0.000223	0.00145	CcSEcCtD
Flurbiprofen—Hepatic failure—Epirubicin—thyroid cancer	0.000223	0.00145	CcSEcCtD
Flurbiprofen—Sepsis—Doxorubicin—thyroid cancer	0.000221	0.00144	CcSEcCtD
Flurbiprofen—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000221	0.00144	CcSEcCtD
Flurbiprofen—ALB—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.00022	0.00555	CbGpPWpGaD
Flurbiprofen—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000218	0.00142	CcSEcCtD
Flurbiprofen—Lymphadenopathy—Doxorubicin—thyroid cancer	0.000217	0.00141	CcSEcCtD
Flurbiprofen—Phlebitis—Doxorubicin—thyroid cancer	0.000215	0.0014	CcSEcCtD
Flurbiprofen—Increased appetite—Epirubicin—thyroid cancer	0.000213	0.00139	CcSEcCtD
Flurbiprofen—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000212	0.00138	CcSEcCtD
Flurbiprofen—Urticaria—Sorafenib—thyroid cancer	0.000211	0.00138	CcSEcCtD
Flurbiprofen—Photosensitivity—Doxorubicin—thyroid cancer	0.000211	0.00137	CcSEcCtD
Flurbiprofen—Body temperature increased—Sorafenib—thyroid cancer	0.00021	0.00137	CcSEcCtD
Flurbiprofen—Abdominal pain—Sorafenib—thyroid cancer	0.00021	0.00137	CcSEcCtD
Flurbiprofen—Renal impairment—Epirubicin—thyroid cancer	0.00021	0.00137	CcSEcCtD
Flurbiprofen—Purpura—Epirubicin—thyroid cancer	0.000208	0.00135	CcSEcCtD
Flurbiprofen—Vascular purpura—Doxorubicin—thyroid cancer	0.000207	0.00135	CcSEcCtD
Flurbiprofen—Eczema—Doxorubicin—thyroid cancer	0.000206	0.00134	CcSEcCtD
Flurbiprofen—Hepatic failure—Doxorubicin—thyroid cancer	0.000206	0.00134	CcSEcCtD
Flurbiprofen—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000204	0.00133	CcSEcCtD
Flurbiprofen—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000204	0.00133	CcSEcCtD
Flurbiprofen—UGT2B4—Metabolism—NDUFA13—thyroid cancer	0.000203	0.00512	CbGpPWpGaD
Flurbiprofen—UGT2B7—NRF2 pathway—SLC5A5—thyroid cancer	0.000201	0.00507	CbGpPWpGaD
Flurbiprofen—Osteoarthritis—Epirubicin—thyroid cancer	0.0002	0.0013	CcSEcCtD
Flurbiprofen—Diplopia—Epirubicin—thyroid cancer	0.0002	0.0013	CcSEcCtD
Flurbiprofen—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.0002	0.0013	CcSEcCtD
Flurbiprofen—UGT1A3—NRF2 pathway—RXRA—thyroid cancer	0.000199	0.00501	CbGpPWpGaD
Flurbiprofen—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000198	0.00499	CbGpPWpGaD
Flurbiprofen—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.000197	0.00497	CbGpPWpGaD
Flurbiprofen—Increased appetite—Doxorubicin—thyroid cancer	0.000197	0.00128	CcSEcCtD
Flurbiprofen—Migraine—Epirubicin—thyroid cancer	0.000197	0.00128	CcSEcCtD
Flurbiprofen—Affect lability—Epirubicin—thyroid cancer	0.000197	0.00128	CcSEcCtD
Flurbiprofen—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000196	0.00128	CcSEcCtD
Flurbiprofen—Hypersensitivity—Sorafenib—thyroid cancer	0.000196	0.00128	CcSEcCtD
Flurbiprofen—Renal impairment—Doxorubicin—thyroid cancer	0.000195	0.00127	CcSEcCtD
Flurbiprofen—Purpura—Doxorubicin—thyroid cancer	0.000192	0.00125	CcSEcCtD
Flurbiprofen—UGT2B4—Metabolism—CHST14—thyroid cancer	0.000191	0.00482	CbGpPWpGaD
Flurbiprofen—Asthenia—Sorafenib—thyroid cancer	0.000191	0.00124	CcSEcCtD
Flurbiprofen—Mood swings—Epirubicin—thyroid cancer	0.00019	0.00123	CcSEcCtD
Flurbiprofen—ABCC4—NRF2 pathway—SLC5A5—thyroid cancer	0.000189	0.00476	CbGpPWpGaD
Flurbiprofen—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000189	0.00123	CcSEcCtD
Flurbiprofen—Pruritus—Sorafenib—thyroid cancer	0.000188	0.00122	CcSEcCtD
Flurbiprofen—Ataxia—Epirubicin—thyroid cancer	0.000188	0.00122	CcSEcCtD
Flurbiprofen—Diplopia—Doxorubicin—thyroid cancer	0.000185	0.0012	CcSEcCtD
Flurbiprofen—Osteoarthritis—Doxorubicin—thyroid cancer	0.000185	0.0012	CcSEcCtD
Flurbiprofen—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000185	0.0012	CcSEcCtD
Flurbiprofen—PTGS1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000185	0.00466	CbGpPWpGaD
Flurbiprofen—Dry skin—Epirubicin—thyroid cancer	0.000183	0.00119	CcSEcCtD
Flurbiprofen—Affect lability—Doxorubicin—thyroid cancer	0.000182	0.00119	CcSEcCtD
Flurbiprofen—Migraine—Doxorubicin—thyroid cancer	0.000182	0.00119	CcSEcCtD
Flurbiprofen—Diarrhoea—Sorafenib—thyroid cancer	0.000182	0.00118	CcSEcCtD
Flurbiprofen—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00018	0.00117	CcSEcCtD
Flurbiprofen—Gastritis—Epirubicin—thyroid cancer	0.000177	0.00115	CcSEcCtD
Flurbiprofen—Muscular weakness—Epirubicin—thyroid cancer	0.000177	0.00115	CcSEcCtD
Flurbiprofen—Dizziness—Sorafenib—thyroid cancer	0.000176	0.00114	CcSEcCtD
Flurbiprofen—Mood swings—Doxorubicin—thyroid cancer	0.000175	0.00114	CcSEcCtD
Flurbiprofen—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	0.000175	0.0044	CbGpPWpGaD
Flurbiprofen—UGT1A3—Biological oxidations—RXRA—thyroid cancer	0.000174	0.00439	CbGpPWpGaD
Flurbiprofen—Abdominal distension—Epirubicin—thyroid cancer	0.000174	0.00113	CcSEcCtD
Flurbiprofen—Ataxia—Doxorubicin—thyroid cancer	0.000174	0.00113	CcSEcCtD
Flurbiprofen—Asthma—Epirubicin—thyroid cancer	0.000173	0.00113	CcSEcCtD
Flurbiprofen—Influenza—Epirubicin—thyroid cancer	0.000173	0.00113	CcSEcCtD
Flurbiprofen—UGT1A9—PPARA activates gene expression—RXRA—thyroid cancer	0.000172	0.00434	CbGpPWpGaD
Flurbiprofen—UGT1A3—NRF2 pathway—NRG1—thyroid cancer	0.000172	0.00433	CbGpPWpGaD
Flurbiprofen—Eosinophilia—Epirubicin—thyroid cancer	0.000171	0.00111	CcSEcCtD
Flurbiprofen—Dry skin—Doxorubicin—thyroid cancer	0.00017	0.0011	CcSEcCtD
Flurbiprofen—Pancreatitis—Epirubicin—thyroid cancer	0.00017	0.0011	CcSEcCtD
Flurbiprofen—Vomiting—Sorafenib—thyroid cancer	0.000169	0.0011	CcSEcCtD
Flurbiprofen—UGT2B7—NRF2 pathway—RXRA—thyroid cancer	0.000169	0.00426	CbGpPWpGaD
Flurbiprofen—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—thyroid cancer	0.000169	0.00425	CbGpPWpGaD
Flurbiprofen—Angina pectoris—Epirubicin—thyroid cancer	0.000169	0.0011	CcSEcCtD
Flurbiprofen—Rash—Sorafenib—thyroid cancer	0.000168	0.00109	CcSEcCtD
Flurbiprofen—Dermatitis—Sorafenib—thyroid cancer	0.000168	0.00109	CcSEcCtD
Flurbiprofen—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000167	0.00108	CcSEcCtD
Flurbiprofen—Headache—Sorafenib—thyroid cancer	0.000167	0.00108	CcSEcCtD
Flurbiprofen—Bronchitis—Epirubicin—thyroid cancer	0.000166	0.00108	CcSEcCtD
Flurbiprofen—PTGS2—Spinal Cord Injury—LGALS3—thyroid cancer	0.000166	0.00419	CbGpPWpGaD
Flurbiprofen—Ketoprofen—PTGS2—thyroid cancer	0.000165	0.0391	CrCbGaD
Flurbiprofen—Pancytopenia—Epirubicin—thyroid cancer	0.000164	0.00107	CcSEcCtD
Flurbiprofen—Gastritis—Doxorubicin—thyroid cancer	0.000164	0.00107	CcSEcCtD
Flurbiprofen—UGT1A1—NRF2 pathway—SLC5A5—thyroid cancer	0.000163	0.00412	CbGpPWpGaD
Flurbiprofen—UGT1A9—NRF2 pathway—SLC5A5—thyroid cancer	0.000163	0.00412	CbGpPWpGaD
Flurbiprofen—Muscular weakness—Doxorubicin—thyroid cancer	0.000163	0.00106	CcSEcCtD
Flurbiprofen—Ibuprofen—PTGS2—thyroid cancer	0.000163	0.0385	CrCbGaD
Flurbiprofen—Dysuria—Epirubicin—thyroid cancer	0.000162	0.00105	CcSEcCtD
Flurbiprofen—Neutropenia—Epirubicin—thyroid cancer	0.000162	0.00105	CcSEcCtD
Flurbiprofen—Abdominal distension—Doxorubicin—thyroid cancer	0.000161	0.00105	CcSEcCtD
Flurbiprofen—Influenza—Doxorubicin—thyroid cancer	0.00016	0.00104	CcSEcCtD
Flurbiprofen—Asthma—Doxorubicin—thyroid cancer	0.00016	0.00104	CcSEcCtD
Flurbiprofen—ABCC4—NRF2 pathway—RXRA—thyroid cancer	0.000159	0.004	CbGpPWpGaD
Flurbiprofen—Eosinophilia—Doxorubicin—thyroid cancer	0.000158	0.00103	CcSEcCtD
Flurbiprofen—Nausea—Sorafenib—thyroid cancer	0.000158	0.00103	CcSEcCtD
Flurbiprofen—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000158	0.00103	CcSEcCtD
Flurbiprofen—Pancreatitis—Doxorubicin—thyroid cancer	0.000157	0.00102	CcSEcCtD
Flurbiprofen—Hyperglycaemia—Epirubicin—thyroid cancer	0.000156	0.00102	CcSEcCtD
Flurbiprofen—Angina pectoris—Doxorubicin—thyroid cancer	0.000156	0.00101	CcSEcCtD
Flurbiprofen—Pneumonia—Epirubicin—thyroid cancer	0.000155	0.00101	CcSEcCtD
Flurbiprofen—ABCC4—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000154	0.00389	CbGpPWpGaD
Flurbiprofen—Drowsiness—Epirubicin—thyroid cancer	0.000154	0.001	CcSEcCtD
Flurbiprofen—UGT2B4—Metabolism—HPGD—thyroid cancer	0.000154	0.00388	CbGpPWpGaD
Flurbiprofen—Bronchitis—Doxorubicin—thyroid cancer	0.000154	0.001	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000153	0.000995	CcSEcCtD
Flurbiprofen—Pancytopenia—Doxorubicin—thyroid cancer	0.000152	0.000989	CcSEcCtD
Flurbiprofen—Renal failure—Epirubicin—thyroid cancer	0.000152	0.000986	CcSEcCtD
Flurbiprofen—Jaundice—Epirubicin—thyroid cancer	0.00015	0.000978	CcSEcCtD
Flurbiprofen—Stomatitis—Epirubicin—thyroid cancer	0.00015	0.000978	CcSEcCtD
Flurbiprofen—Urinary tract infection—Epirubicin—thyroid cancer	0.00015	0.000975	CcSEcCtD
Flurbiprofen—Conjunctivitis—Epirubicin—thyroid cancer	0.00015	0.000975	CcSEcCtD
Flurbiprofen—Dysuria—Doxorubicin—thyroid cancer	0.00015	0.000974	CcSEcCtD
Flurbiprofen—Neutropenia—Doxorubicin—thyroid cancer	0.00015	0.000974	CcSEcCtD
Flurbiprofen—UGT2B7—Biological oxidations—RXRA—thyroid cancer	0.000148	0.00373	CbGpPWpGaD
Flurbiprofen—Sweating—Epirubicin—thyroid cancer	0.000148	0.000962	CcSEcCtD
Flurbiprofen—Haematuria—Epirubicin—thyroid cancer	0.000147	0.000957	CcSEcCtD
Flurbiprofen—UGT2B7—NRF2 pathway—NRG1—thyroid cancer	0.000146	0.00368	CbGpPWpGaD
Flurbiprofen—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000146	0.00095	CcSEcCtD
Flurbiprofen—Epistaxis—Epirubicin—thyroid cancer	0.000145	0.000946	CcSEcCtD
Flurbiprofen—Sinusitis—Epirubicin—thyroid cancer	0.000145	0.000941	CcSEcCtD
Flurbiprofen—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000144	0.000939	CcSEcCtD
Flurbiprofen—Agranulocytosis—Epirubicin—thyroid cancer	0.000144	0.000936	CcSEcCtD
Flurbiprofen—Pneumonia—Doxorubicin—thyroid cancer	0.000144	0.000934	CcSEcCtD
Flurbiprofen—Drowsiness—Doxorubicin—thyroid cancer	0.000143	0.000928	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000141	0.00092	CcSEcCtD
Flurbiprofen—Renal failure—Doxorubicin—thyroid cancer	0.00014	0.000913	CcSEcCtD
Flurbiprofen—Haemoglobin—Epirubicin—thyroid cancer	0.000139	0.000905	CcSEcCtD
Flurbiprofen—Stomatitis—Doxorubicin—thyroid cancer	0.000139	0.000905	CcSEcCtD
Flurbiprofen—Jaundice—Doxorubicin—thyroid cancer	0.000139	0.000905	CcSEcCtD
Flurbiprofen—Rhinitis—Epirubicin—thyroid cancer	0.000139	0.000903	CcSEcCtD
Flurbiprofen—Urinary tract infection—Doxorubicin—thyroid cancer	0.000139	0.000902	CcSEcCtD
Flurbiprofen—Conjunctivitis—Doxorubicin—thyroid cancer	0.000139	0.000902	CcSEcCtD
Flurbiprofen—SLC22A6—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000139	0.00349	CbGpPWpGaD
Flurbiprofen—SLC22A6—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000139	0.00349	CbGpPWpGaD
Flurbiprofen—Haemorrhage—Epirubicin—thyroid cancer	0.000138	0.000901	CcSEcCtD
Flurbiprofen—Hepatitis—Epirubicin—thyroid cancer	0.000138	0.000901	CcSEcCtD
Flurbiprofen—Pharyngitis—Epirubicin—thyroid cancer	0.000137	0.000894	CcSEcCtD
Flurbiprofen—ABCC4—NRF2 pathway—NRG1—thyroid cancer	0.000137	0.00346	CbGpPWpGaD
Flurbiprofen—UGT1A9—NRF2 pathway—RXRA—thyroid cancer	0.000137	0.00346	CbGpPWpGaD
Flurbiprofen—UGT1A1—NRF2 pathway—RXRA—thyroid cancer	0.000137	0.00346	CbGpPWpGaD
Flurbiprofen—Sweating—Doxorubicin—thyroid cancer	0.000137	0.00089	CcSEcCtD
Flurbiprofen—Haematuria—Doxorubicin—thyroid cancer	0.000136	0.000885	CcSEcCtD
Flurbiprofen—Epistaxis—Doxorubicin—thyroid cancer	0.000135	0.000876	CcSEcCtD
Flurbiprofen—Sinusitis—Doxorubicin—thyroid cancer	0.000134	0.000871	CcSEcCtD
Flurbiprofen—Visual impairment—Epirubicin—thyroid cancer	0.000133	0.000868	CcSEcCtD
Flurbiprofen—Agranulocytosis—Doxorubicin—thyroid cancer	0.000133	0.000866	CcSEcCtD
Flurbiprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—thyroid cancer	0.000132	0.00333	CbGpPWpGaD
Flurbiprofen—PTGS1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000131	0.0033	CbGpPWpGaD
Flurbiprofen—Erythema multiforme—Epirubicin—thyroid cancer	0.000131	0.000852	CcSEcCtD
Flurbiprofen—Tinnitus—Epirubicin—thyroid cancer	0.000129	0.00084	CcSEcCtD
Flurbiprofen—Haemoglobin—Doxorubicin—thyroid cancer	0.000129	0.000838	CcSEcCtD
Flurbiprofen—Rhinitis—Doxorubicin—thyroid cancer	0.000128	0.000835	CcSEcCtD
Flurbiprofen—Hepatitis—Doxorubicin—thyroid cancer	0.000128	0.000833	CcSEcCtD
Flurbiprofen—Haemorrhage—Doxorubicin—thyroid cancer	0.000128	0.000833	CcSEcCtD
Flurbiprofen—UGT1A3—Metabolism—MINPP1—thyroid cancer	0.000128	0.00323	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000128	0.00323	CbGpPWpGaD
Flurbiprofen—Pharyngitis—Doxorubicin—thyroid cancer	0.000127	0.000827	CcSEcCtD
Flurbiprofen—Angiopathy—Epirubicin—thyroid cancer	0.000126	0.000817	CcSEcCtD
Flurbiprofen—Chills—Epirubicin—thyroid cancer	0.000124	0.000808	CcSEcCtD
Flurbiprofen—Arrhythmia—Epirubicin—thyroid cancer	0.000124	0.000805	CcSEcCtD
Flurbiprofen—Visual impairment—Doxorubicin—thyroid cancer	0.000123	0.000803	CcSEcCtD
Flurbiprofen—Alopecia—Epirubicin—thyroid cancer	0.000122	0.000796	CcSEcCtD
Flurbiprofen—Erythema multiforme—Doxorubicin—thyroid cancer	0.000121	0.000788	CcSEcCtD
Flurbiprofen—UGT1A1—Biological oxidations—RXRA—thyroid cancer	0.00012	0.00303	CbGpPWpGaD
Flurbiprofen—UGT1A9—Biological oxidations—RXRA—thyroid cancer	0.00012	0.00303	CbGpPWpGaD
Flurbiprofen—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00012	0.00302	CbGpPWpGaD
Flurbiprofen—Tinnitus—Doxorubicin—thyroid cancer	0.000119	0.000777	CcSEcCtD
Flurbiprofen—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000119	0.003	CbGpPWpGaD
Flurbiprofen—Flatulence—Epirubicin—thyroid cancer	0.000119	0.000773	CcSEcCtD
Flurbiprofen—UGT1A1—NRF2 pathway—NRG1—thyroid cancer	0.000119	0.00299	CbGpPWpGaD
Flurbiprofen—UGT1A9—NRF2 pathway—NRG1—thyroid cancer	0.000119	0.00299	CbGpPWpGaD
Flurbiprofen—Tension—Epirubicin—thyroid cancer	0.000118	0.000769	CcSEcCtD
Flurbiprofen—Nervousness—Epirubicin—thyroid cancer	0.000117	0.000761	CcSEcCtD
Flurbiprofen—Angiopathy—Doxorubicin—thyroid cancer	0.000116	0.000756	CcSEcCtD
Flurbiprofen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000116	0.00293	CbGpPWpGaD
Flurbiprofen—Chills—Doxorubicin—thyroid cancer	0.000115	0.000748	CcSEcCtD
Flurbiprofen—Arrhythmia—Doxorubicin—thyroid cancer	0.000114	0.000744	CcSEcCtD
Flurbiprofen—PTGS2—Spinal Cord Injury—CDK1—thyroid cancer	0.000114	0.00286	CbGpPWpGaD
Flurbiprofen—Alopecia—Doxorubicin—thyroid cancer	0.000113	0.000736	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Epirubicin—thyroid cancer	0.000112	0.000727	CcSEcCtD
Flurbiprofen—Anaemia—Epirubicin—thyroid cancer	0.000111	0.000725	CcSEcCtD
Flurbiprofen—Flatulence—Doxorubicin—thyroid cancer	0.00011	0.000715	CcSEcCtD
Flurbiprofen—Tension—Doxorubicin—thyroid cancer	0.000109	0.000712	CcSEcCtD
Flurbiprofen—UGT1A3—Metabolism—NDUFA13—thyroid cancer	0.000109	0.00274	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—MINPP1—thyroid cancer	0.000109	0.00274	CbGpPWpGaD
Flurbiprofen—UGT1A9—PPARA activates gene expression—PPARG—thyroid cancer	0.000109	0.00274	CbGpPWpGaD
Flurbiprofen—Malaise—Epirubicin—thyroid cancer	0.000109	0.000707	CcSEcCtD
Flurbiprofen—Nervousness—Doxorubicin—thyroid cancer	0.000108	0.000705	CcSEcCtD
Flurbiprofen—Vertigo—Epirubicin—thyroid cancer	0.000108	0.000704	CcSEcCtD
Flurbiprofen—Syncope—Epirubicin—thyroid cancer	0.000108	0.000703	CcSEcCtD
Flurbiprofen—Leukopenia—Epirubicin—thyroid cancer	0.000108	0.000702	CcSEcCtD
Flurbiprofen—Palpitations—Epirubicin—thyroid cancer	0.000107	0.000693	CcSEcCtD
Flurbiprofen—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	0.000106	0.00268	CbGpPWpGaD
Flurbiprofen—Loss of consciousness—Epirubicin—thyroid cancer	0.000106	0.000689	CcSEcCtD
Flurbiprofen—Cough—Epirubicin—thyroid cancer	0.000105	0.000684	CcSEcCtD
Flurbiprofen—Convulsion—Epirubicin—thyroid cancer	0.000104	0.000679	CcSEcCtD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000104	0.00263	CbGpPWpGaD
Flurbiprofen—Hypertension—Epirubicin—thyroid cancer	0.000104	0.000677	CcSEcCtD
Flurbiprofen—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000104	0.00261	CbGpPWpGaD
Flurbiprofen—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000103	0.000673	CcSEcCtD
Flurbiprofen—Anaemia—Doxorubicin—thyroid cancer	0.000103	0.000671	CcSEcCtD
Flurbiprofen—Myalgia—Epirubicin—thyroid cancer	0.000103	0.000667	CcSEcCtD
Flurbiprofen—UGT1A3—Metabolism—CHST14—thyroid cancer	0.000102	0.00258	CbGpPWpGaD
Flurbiprofen—Anxiety—Epirubicin—thyroid cancer	0.000102	0.000665	CcSEcCtD
Flurbiprofen—Discomfort—Epirubicin—thyroid cancer	0.000101	0.000659	CcSEcCtD
Flurbiprofen—Malaise—Doxorubicin—thyroid cancer	0.000101	0.000654	CcSEcCtD
Flurbiprofen—Dry mouth—Epirubicin—thyroid cancer	0.0001	0.000653	CcSEcCtD
Flurbiprofen—Vertigo—Doxorubicin—thyroid cancer	0.0001	0.000652	CcSEcCtD
Flurbiprofen—Syncope—Doxorubicin—thyroid cancer	0.0001	0.000651	CcSEcCtD
Flurbiprofen—Leukopenia—Doxorubicin—thyroid cancer	9.98e-05	0.000649	CcSEcCtD
Flurbiprofen—Confusional state—Epirubicin—thyroid cancer	9.92e-05	0.000645	CcSEcCtD
Flurbiprofen—Palpitations—Doxorubicin—thyroid cancer	9.86e-05	0.000641	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Epirubicin—thyroid cancer	9.84e-05	0.00064	CcSEcCtD
Flurbiprofen—Oedema—Epirubicin—thyroid cancer	9.84e-05	0.00064	CcSEcCtD
Flurbiprofen—PTGS1—Biological oxidations—RXRA—thyroid cancer	9.82e-05	0.00247	CbGpPWpGaD
Flurbiprofen—Loss of consciousness—Doxorubicin—thyroid cancer	9.8e-05	0.000638	CcSEcCtD
Flurbiprofen—Infection—Epirubicin—thyroid cancer	9.77e-05	0.000636	CcSEcCtD
Flurbiprofen—Cough—Doxorubicin—thyroid cancer	9.73e-05	0.000633	CcSEcCtD
Flurbiprofen—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	9.72e-05	0.00245	CbGpPWpGaD
Flurbiprofen—Shock—Epirubicin—thyroid cancer	9.68e-05	0.00063	CcSEcCtD
Flurbiprofen—Convulsion—Doxorubicin—thyroid cancer	9.66e-05	0.000629	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Epirubicin—thyroid cancer	9.63e-05	0.000627	CcSEcCtD
Flurbiprofen—Hypertension—Doxorubicin—thyroid cancer	9.63e-05	0.000626	CcSEcCtD
Flurbiprofen—Tachycardia—Epirubicin—thyroid cancer	9.6e-05	0.000625	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Epirubicin—thyroid cancer	9.51e-05	0.000619	CcSEcCtD
Flurbiprofen—Myalgia—Doxorubicin—thyroid cancer	9.5e-05	0.000618	CcSEcCtD
Flurbiprofen—Anxiety—Doxorubicin—thyroid cancer	9.46e-05	0.000615	CcSEcCtD
Flurbiprofen—Discomfort—Doxorubicin—thyroid cancer	9.38e-05	0.00061	CcSEcCtD
Flurbiprofen—Anorexia—Epirubicin—thyroid cancer	9.38e-05	0.00061	CcSEcCtD
Flurbiprofen—Dry mouth—Doxorubicin—thyroid cancer	9.29e-05	0.000604	CcSEcCtD
Flurbiprofen—UGT2B7—Metabolism—NDUFA13—thyroid cancer	9.26e-05	0.00233	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—PRKAR1A—thyroid cancer	9.19e-05	0.00232	CbGpPWpGaD
Flurbiprofen—Hypotension—Epirubicin—thyroid cancer	9.19e-05	0.000598	CcSEcCtD
Flurbiprofen—Confusional state—Doxorubicin—thyroid cancer	9.18e-05	0.000597	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Doxorubicin—thyroid cancer	9.1e-05	0.000592	CcSEcCtD
Flurbiprofen—Oedema—Doxorubicin—thyroid cancer	9.1e-05	0.000592	CcSEcCtD
Flurbiprofen—Infection—Doxorubicin—thyroid cancer	9.04e-05	0.000588	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Epirubicin—thyroid cancer	8.96e-05	0.000583	CcSEcCtD
Flurbiprofen—Shock—Doxorubicin—thyroid cancer	8.96e-05	0.000582	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Doxorubicin—thyroid cancer	8.91e-05	0.00058	CcSEcCtD
Flurbiprofen—Insomnia—Epirubicin—thyroid cancer	8.9e-05	0.000579	CcSEcCtD
Flurbiprofen—Tachycardia—Doxorubicin—thyroid cancer	8.88e-05	0.000578	CcSEcCtD
Flurbiprofen—UGT1A1—Metabolism—MINPP1—thyroid cancer	8.85e-05	0.00223	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—TPR—thyroid cancer	8.85e-05	0.00223	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—MINPP1—thyroid cancer	8.85e-05	0.00223	CbGpPWpGaD
Flurbiprofen—Paraesthesia—Epirubicin—thyroid cancer	8.83e-05	0.000575	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Doxorubicin—thyroid cancer	8.8e-05	0.000572	CcSEcCtD
Flurbiprofen—Dyspnoea—Epirubicin—thyroid cancer	8.77e-05	0.00057	CcSEcCtD
Flurbiprofen—Somnolence—Epirubicin—thyroid cancer	8.75e-05	0.000569	CcSEcCtD
Flurbiprofen—UGT2B4—Metabolism—PRKAR1A—thyroid cancer	8.7e-05	0.00219	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CHST14—thyroid cancer	8.7e-05	0.00219	CbGpPWpGaD
Flurbiprofen—Anorexia—Doxorubicin—thyroid cancer	8.68e-05	0.000564	CcSEcCtD
Flurbiprofen—Dyspepsia—Epirubicin—thyroid cancer	8.66e-05	0.000563	CcSEcCtD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	8.65e-05	0.00218	CbGpPWpGaD
Flurbiprofen—Decreased appetite—Epirubicin—thyroid cancer	8.55e-05	0.000556	CcSEcCtD
Flurbiprofen—Hypotension—Doxorubicin—thyroid cancer	8.51e-05	0.000553	CcSEcCtD
Flurbiprofen—Constipation—Epirubicin—thyroid cancer	8.41e-05	0.000547	CcSEcCtD
Flurbiprofen—Pain—Epirubicin—thyroid cancer	8.41e-05	0.000547	CcSEcCtD
Flurbiprofen—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	8.34e-05	0.0021	CbGpPWpGaD
Flurbiprofen—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	8.29e-05	0.000539	CcSEcCtD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	8.28e-05	0.00209	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—HPGD—thyroid cancer	8.25e-05	0.00208	CbGpPWpGaD
Flurbiprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	8.23e-05	0.00207	CbGpPWpGaD
Flurbiprofen—Insomnia—Doxorubicin—thyroid cancer	8.23e-05	0.000535	CcSEcCtD
Flurbiprofen—Paraesthesia—Doxorubicin—thyroid cancer	8.17e-05	0.000532	CcSEcCtD
Flurbiprofen—Dyspnoea—Doxorubicin—thyroid cancer	8.12e-05	0.000528	CcSEcCtD
Flurbiprofen—Feeling abnormal—Epirubicin—thyroid cancer	8.11e-05	0.000527	CcSEcCtD
Flurbiprofen—Somnolence—Doxorubicin—thyroid cancer	8.09e-05	0.000526	CcSEcCtD
Flurbiprofen—ABCC4—Transmembrane transport of small molecules—TPR—thyroid cancer	8.09e-05	0.00204	CbGpPWpGaD
Flurbiprofen—ABCC4—Transmembrane transport of small molecules—CP—thyroid cancer	8.09e-05	0.00204	CbGpPWpGaD
Flurbiprofen—Gastrointestinal pain—Epirubicin—thyroid cancer	8.04e-05	0.000523	CcSEcCtD
Flurbiprofen—Dyspepsia—Doxorubicin—thyroid cancer	8.01e-05	0.000521	CcSEcCtD
Flurbiprofen—ABCC4—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.96e-05	0.00201	CbGpPWpGaD
Flurbiprofen—Decreased appetite—Doxorubicin—thyroid cancer	7.91e-05	0.000515	CcSEcCtD
Flurbiprofen—Urticaria—Epirubicin—thyroid cancer	7.81e-05	0.000508	CcSEcCtD
Flurbiprofen—Pain—Doxorubicin—thyroid cancer	7.78e-05	0.000506	CcSEcCtD
Flurbiprofen—Constipation—Doxorubicin—thyroid cancer	7.78e-05	0.000506	CcSEcCtD
Flurbiprofen—Abdominal pain—Epirubicin—thyroid cancer	7.78e-05	0.000506	CcSEcCtD
Flurbiprofen—Body temperature increased—Epirubicin—thyroid cancer	7.78e-05	0.000506	CcSEcCtD
Flurbiprofen—UGT1A1—Metabolism—NDUFA13—thyroid cancer	7.52e-05	0.0019	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—NDUFA13—thyroid cancer	7.52e-05	0.0019	CbGpPWpGaD
Flurbiprofen—Feeling abnormal—Doxorubicin—thyroid cancer	7.5e-05	0.000488	CcSEcCtD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	7.45e-05	0.00188	CbGpPWpGaD
Flurbiprofen—Gastrointestinal pain—Doxorubicin—thyroid cancer	7.44e-05	0.000484	CcSEcCtD
Flurbiprofen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	7.33e-05	0.00185	CbGpPWpGaD
Flurbiprofen—Hypersensitivity—Epirubicin—thyroid cancer	7.25e-05	0.000471	CcSEcCtD
Flurbiprofen—Urticaria—Doxorubicin—thyroid cancer	7.23e-05	0.00047	CcSEcCtD
Flurbiprofen—PTGS1—Metabolism—MINPP1—thyroid cancer	7.21e-05	0.00182	CbGpPWpGaD
Flurbiprofen—ALB—SLC-mediated transmembrane transport—CP—thyroid cancer	7.2e-05	0.00181	CbGpPWpGaD
Flurbiprofen—ALB—SLC-mediated transmembrane transport—TPR—thyroid cancer	7.2e-05	0.00181	CbGpPWpGaD
Flurbiprofen—Body temperature increased—Doxorubicin—thyroid cancer	7.2e-05	0.000468	CcSEcCtD
Flurbiprofen—Abdominal pain—Doxorubicin—thyroid cancer	7.2e-05	0.000468	CcSEcCtD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	7.17e-05	0.00181	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CHST14—thyroid cancer	7.07e-05	0.00178	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CHST14—thyroid cancer	7.07e-05	0.00178	CbGpPWpGaD
Flurbiprofen—Asthenia—Epirubicin—thyroid cancer	7.06e-05	0.000459	CcSEcCtD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—CP—thyroid cancer	7.04e-05	0.00177	CbGpPWpGaD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—TPR—thyroid cancer	7.04e-05	0.00177	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—HPGD—thyroid cancer	7.02e-05	0.00177	CbGpPWpGaD
Flurbiprofen—Pruritus—Epirubicin—thyroid cancer	6.96e-05	0.000453	CcSEcCtD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	6.93e-05	0.00175	CbGpPWpGaD
Flurbiprofen—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	6.89e-05	0.00174	CbGpPWpGaD
Flurbiprofen—Diarrhoea—Epirubicin—thyroid cancer	6.73e-05	0.000438	CcSEcCtD
Flurbiprofen—Hypersensitivity—Doxorubicin—thyroid cancer	6.71e-05	0.000436	CcSEcCtD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	6.7e-05	0.00169	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—SLC5A5—thyroid cancer	6.62e-05	0.00167	CbGpPWpGaD
Flurbiprofen—Asthenia—Doxorubicin—thyroid cancer	6.53e-05	0.000425	CcSEcCtD
Flurbiprofen—Dizziness—Epirubicin—thyroid cancer	6.51e-05	0.000423	CcSEcCtD
Flurbiprofen—Pruritus—Doxorubicin—thyroid cancer	6.44e-05	0.000419	CcSEcCtD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	6.33e-05	0.00159	CbGpPWpGaD
Flurbiprofen—Vomiting—Epirubicin—thyroid cancer	6.25e-05	0.000407	CcSEcCtD
Flurbiprofen—Diarrhoea—Doxorubicin—thyroid cancer	6.23e-05	0.000405	CcSEcCtD
Flurbiprofen—PTGS2—C-MYB transcription factor network—CCND1—thyroid cancer	6.21e-05	0.00156	CbGpPWpGaD
Flurbiprofen—Rash—Epirubicin—thyroid cancer	6.2e-05	0.000403	CcSEcCtD
Flurbiprofen—Dermatitis—Epirubicin—thyroid cancer	6.2e-05	0.000403	CcSEcCtD
Flurbiprofen—Headache—Epirubicin—thyroid cancer	6.16e-05	0.000401	CcSEcCtD
Flurbiprofen—PTGS1—Metabolism—NDUFA13—thyroid cancer	6.13e-05	0.00155	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—IFNA2—thyroid cancer	6.09e-05	0.00153	CbGpPWpGaD
Flurbiprofen—ABCC4—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.06e-05	0.00153	CbGpPWpGaD
Flurbiprofen—Dizziness—Doxorubicin—thyroid cancer	6.02e-05	0.000392	CcSEcCtD
Flurbiprofen—Nausea—Epirubicin—thyroid cancer	5.84e-05	0.00038	CcSEcCtD
Flurbiprofen—PTGS2—Disease—TRIM24—thyroid cancer	5.81e-05	0.00146	CbGpPWpGaD
Flurbiprofen—Vomiting—Doxorubicin—thyroid cancer	5.79e-05	0.000376	CcSEcCtD
Flurbiprofen—PTGS1—Metabolism—CHST14—thyroid cancer	5.77e-05	0.00145	CbGpPWpGaD
Flurbiprofen—Rash—Doxorubicin—thyroid cancer	5.74e-05	0.000373	CcSEcCtD
Flurbiprofen—Dermatitis—Doxorubicin—thyroid cancer	5.73e-05	0.000373	CcSEcCtD
Flurbiprofen—PTGS2—Metabolism—MINPP1—thyroid cancer	5.73e-05	0.00144	CbGpPWpGaD
Flurbiprofen—Headache—Doxorubicin—thyroid cancer	5.7e-05	0.000371	CcSEcCtD
Flurbiprofen—UGT1A9—Metabolism—HPGD—thyroid cancer	5.7e-05	0.00144	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—HPGD—thyroid cancer	5.7e-05	0.00144	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—RXRA—thyroid cancer	5.56e-05	0.0014	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.49e-05	0.00138	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CHST14—thyroid cancer	5.47e-05	0.00138	CbGpPWpGaD
Flurbiprofen—Nausea—Doxorubicin—thyroid cancer	5.41e-05	0.000352	CcSEcCtD
Flurbiprofen—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	5.39e-05	0.00136	CbGpPWpGaD
Flurbiprofen—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	5.35e-05	0.00135	CbGpPWpGaD
Flurbiprofen—PTGS2—C-MYB transcription factor network—NRAS—thyroid cancer	5.34e-05	0.00135	CbGpPWpGaD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.27e-05	0.00133	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—TRIM33—thyroid cancer	5.18e-05	0.00131	CbGpPWpGaD
Flurbiprofen—CYP2C9—Biological oxidations—RXRA—thyroid cancer	5.16e-05	0.0013	CbGpPWpGaD
Flurbiprofen—ABCC4—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.09e-05	0.00128	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—NDUFA13—thyroid cancer	4.87e-05	0.00123	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—TPR—thyroid cancer	4.74e-05	0.00119	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—CCND1—thyroid cancer	4.73e-05	0.00119	CbGpPWpGaD
Flurbiprofen—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	4.68e-05	0.00118	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PRKAR1A—thyroid cancer	4.66e-05	0.00117	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—HPGD—thyroid cancer	4.65e-05	0.00117	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—MINPP1—thyroid cancer	4.63e-05	0.00117	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.62e-05	0.00117	CbGpPWpGaD
Flurbiprofen—PTGS2—C-MYB transcription factor network—KRAS—thyroid cancer	4.6e-05	0.00116	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CHST14—thyroid cancer	4.58e-05	0.00115	CbGpPWpGaD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.43e-05	0.00112	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PRKAR1A—thyroid cancer	4.16e-05	0.00105	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—TPR—thyroid cancer	4.03e-05	0.00102	CbGpPWpGaD
Flurbiprofen—ALB—Folate Metabolism—TP53—thyroid cancer	4.01e-05	0.00101	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PRKAR1A—thyroid cancer	3.96e-05	0.000999	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NDUFA13—thyroid cancer	3.94e-05	0.000992	CbGpPWpGaD
Flurbiprofen—PTGS2—C-MYB transcription factor network—HRAS—thyroid cancer	3.91e-05	0.000985	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—MINPP1—thyroid cancer	3.79e-05	0.000955	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.77e-05	0.00095	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CHST14—thyroid cancer	3.7e-05	0.000933	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—HPGD—thyroid cancer	3.69e-05	0.00093	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	3.66e-05	0.000922	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	3.66e-05	0.000922	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.6e-05	0.000907	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—SLC5A5—thyroid cancer	3.55e-05	0.000894	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PPARG—thyroid cancer	3.51e-05	0.000885	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—TCF7L1—thyroid cancer	3.46e-05	0.000871	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—TPR—thyroid cancer	3.27e-05	0.000825	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—TPR—thyroid cancer	3.27e-05	0.000825	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NDUFA13—thyroid cancer	3.22e-05	0.000812	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PRKAR1A—thyroid cancer	3.22e-05	0.000812	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PRKAR1A—thyroid cancer	3.22e-05	0.000812	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	3.22e-05	0.00081	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	3.11e-05	0.000785	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	3.1e-05	0.000782	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CHST14—thyroid cancer	3.03e-05	0.000764	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—SLC5A5—thyroid cancer	3.02e-05	0.00076	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.99e-05	0.000754	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—HPGD—thyroid cancer	2.99e-05	0.000752	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—RXRA—thyroid cancer	2.98e-05	0.000751	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.92e-05	0.000736	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.85e-05	0.000717	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PTGS2—thyroid cancer	2.76e-05	0.000696	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—IFNA2—thyroid cancer	2.76e-05	0.000694	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.74e-05	0.00069	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—TPR—thyroid cancer	2.67e-05	0.000673	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PRKAR1A—thyroid cancer	2.63e-05	0.000662	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—RXRA—thyroid cancer	2.53e-05	0.000639	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—TPR—thyroid cancer	2.53e-05	0.000638	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PRKAR1A—thyroid cancer	2.49e-05	0.000627	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—SLC5A5—thyroid cancer	2.45e-05	0.000618	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—SLC5A5—thyroid cancer	2.45e-05	0.000618	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—HPGD—thyroid cancer	2.44e-05	0.000616	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.42e-05	0.00061	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PTEN—thyroid cancer	2.41e-05	0.000607	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.38e-05	0.000601	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.38e-05	0.0006	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MEN1—thyroid cancer	2.38e-05	0.000599	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.3e-05	0.00058	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.3e-05	0.000579	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—NRAS—thyroid cancer	2.27e-05	0.000572	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—TPR—thyroid cancer	2.12e-05	0.000534	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.12e-05	0.000534	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PRKAR1A—thyroid cancer	2.08e-05	0.000525	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—RXRA—thyroid cancer	2.06e-05	0.000519	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—RXRA—thyroid cancer	2.06e-05	0.000519	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2e-05	0.000505	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—SLC5A5—thyroid cancer	2e-05	0.000503	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.98e-05	0.000499	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—KRAS—thyroid cancer	1.95e-05	0.000493	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CALCA—thyroid cancer	1.89e-05	0.000477	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.89e-05	0.000476	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PPARG—thyroid cancer	1.88e-05	0.000474	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.87e-05	0.000472	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.79e-05	0.000451	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—TP53—thyroid cancer	1.74e-05	0.000438	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CDK1—thyroid cancer	1.71e-05	0.000432	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—TPR—thyroid cancer	1.71e-05	0.000432	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PRKAR1A—thyroid cancer	1.69e-05	0.000425	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—RXRA—thyroid cancer	1.68e-05	0.000423	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—HRAS—thyroid cancer	1.66e-05	0.000419	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.63e-05	0.000411	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PPARG—thyroid cancer	1.6e-05	0.000403	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—SLC5A5—thyroid cancer	1.59e-05	0.0004	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.53e-05	0.000385	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PTGS2—thyroid cancer	1.48e-05	0.000373	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—AKT1—thyroid cancer	1.47e-05	0.00037	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—TPR—thyroid cancer	1.4e-05	0.000354	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—AKT1—thyroid cancer	1.39e-05	0.00035	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.38e-05	0.000348	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NRG1—thyroid cancer	1.38e-05	0.000347	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—RXRA—thyroid cancer	1.33e-05	0.000336	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PPARG—thyroid cancer	1.3e-05	0.000328	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PPARG—thyroid cancer	1.3e-05	0.000328	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.3e-05	0.000327	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PTEN—thyroid cancer	1.29e-05	0.000325	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.29e-05	0.000325	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—SLC5A5—thyroid cancer	1.28e-05	0.000323	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PTGS2—thyroid cancer	1.26e-05	0.000317	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.25e-05	0.000315	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—TERT—thyroid cancer	1.24e-05	0.000311	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.2e-05	0.000303	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HIF1A—thyroid cancer	1.18e-05	0.000298	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PTEN—thyroid cancer	1.1e-05	0.000277	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—RXRA—thyroid cancer	1.08e-05	0.000272	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PPARG—thyroid cancer	1.06e-05	0.000267	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.05e-05	0.000265	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.05e-05	0.000264	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—NRAS—thyroid cancer	1.03e-05	0.000259	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PTGS2—thyroid cancer	1.02e-05	0.000258	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PTGS2—thyroid cancer	1.02e-05	0.000258	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.84e-06	0.000248	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—BRAF—thyroid cancer	9.79e-06	0.000247	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PTEN—thyroid cancer	8.92e-06	0.000225	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PTEN—thyroid cancer	8.92e-06	0.000225	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—KRAS—thyroid cancer	8.85e-06	0.000223	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—RXRA—thyroid cancer	8.83e-06	0.000222	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.58e-06	0.000216	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PPARG—thyroid cancer	8.42e-06	0.000212	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PTGS2—thyroid cancer	8.34e-06	0.00021	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—TP53—thyroid cancer	7.86e-06	0.000198	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—HRAS—thyroid cancer	7.52e-06	0.000189	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—AKT1—thyroid cancer	7.44e-06	0.000187	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PTEN—thyroid cancer	7.27e-06	0.000183	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PTEN—thyroid cancer	6.89e-06	0.000174	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PPARG—thyroid cancer	6.81e-06	0.000172	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—AKT1—thyroid cancer	6.64e-06	0.000167	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—AKT1—thyroid cancer	6.33e-06	0.000159	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NRAS—thyroid cancer	6.15e-06	0.000155	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PTEN—thyroid cancer	5.77e-06	0.000145	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PPARG—thyroid cancer	5.57e-06	0.00014	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PTGS2—thyroid cancer	5.36e-06	0.000135	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—KRAS—thyroid cancer	5.29e-06	0.000133	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—AKT1—thyroid cancer	5.14e-06	0.00013	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—AKT1—thyroid cancer	5.14e-06	0.00013	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PTEN—thyroid cancer	4.67e-06	0.000118	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HRAS—thyroid cancer	4.5e-06	0.000113	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PTGS2—thyroid cancer	4.38e-06	0.00011	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—AKT1—thyroid cancer	4.19e-06	0.000106	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—AKT1—thyroid cancer	3.97e-06	0.0001	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PTEN—thyroid cancer	3.82e-06	9.63e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—AKT1—thyroid cancer	3.33e-06	8.38e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—AKT1—thyroid cancer	2.69e-06	6.78e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—AKT1—thyroid cancer	2.2e-06	5.55e-05	CbGpPWpGaD
